How does ALPRAZOLAM ODT C-IV work?

ALPRAZOLAM ODT C-IV works through the following mechanism: Benzodiazepine agent.

What are the most common side effects of ALPRAZOLAM ODT C-IV?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ALPRAZOLAM ODT C-IV. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is ALPRAZOLAM ODT C-IV the same as Alprazolam ODT C-IV?

Alprazolam ODT C-IV is a brand name for ALPRAZOLAM ODT C-IV. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ALPRAZOLAM ODT C-IV

Q: What is ALPRAZOLAM ODT C-IV used for?

ALPRAZOLAM ODT C-IV (brand name Alprazolam ODT C-IV) is a Benzodiazepine indicated for 1.1 Generalized Anxiety Disorder Alprazolam orally disintegrating tablets, USP are indicated for the treatment of generalized anxiety disorder. The efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term, placebo-controlled trials [see Clinical Studies (14.1)]. 1.2 Panic Disorder Alprazolam orally disintegrating tablets.

Benzodiazepine

Brand names: Alprazolam ODT C-IV

Oral

Mechanism of Action

Benzodiazepine agent

Indications

1.1 Generalized Anxiety Disorder Alprazolam orally disintegrating tablets

USP are indicated for the treatment of generalized anxiety disorder. The efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term

placebo-controlled trials [see Clinical Studies (14.1)]. 1.2 Panic Disorder Alprazolam orally disintegrating tablets

USP are also indicated for the treatment of panic disorder

with or without agoraphobia. The efficacy of alprazolam in the treatment of panic disorder was established in 2 short-term

however

Contraindications

• ketoconazole and itraconazole)
• because these medications significantly impair the oxidative metabolism mediated by cytochrome P450 3A (CYP3A) and can increase alprazolam exposures [see Clinical Pharmacology (12.3)
• Warnings and Precautions (5.9)
• and Drug Interactions (7.4)].

FDA Warnings

1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone
Advise both patients and caregivers about the risks of respiratory depression and sedation when alprazolam is used with opioids

Known Side Effects

11 documented side effects by frequency

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

Depression

1-10%

Insomnia

1-10%

Vomiting

1-10%

Community Discussions

No community discussions found for ALPRAZOLAM ODT C-IV yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → ALPRAZOLAM ODT C-IV openFDA label JSON → ALPRAZOLAM ODT C-IV FAERS adverse-event reports → ALPRAZOLAM ODT C-IV ClinicalTrials.gov → completed Phase 2+ trials of ALPRAZOLAM ODT C-IV

Compare With

14 available comparisons

Formulations

Dosage Forms

Tablet

Route

Oral